Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Oil-in-water compound chlortetracycline nanoemulsion

A compound chlortetracycline and oil-in-water technology, applied in the field of medicine, can solve the problems of increased administration frequency and administration dosage, poor water solubility of chlortetracycline, poor bioavailability, etc. The effect of reducing kidney damage and improving antibacterial ability

Inactive Publication Date: 2015-02-18
HENAN SOAR VETERINARY PHARMA
View PDF4 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, chlortetracycline has poor water solubility, is often difficult to be absorbed and transported by the body, and has extremely poor bioavailability. When used as a veterinary drug, it is easy to increase the number of administrations and dosages, and the accumulation of drug residues in animals will also endanger human health.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Oil-in-water compound chlortetracycline nanoemulsion
  • Oil-in-water compound chlortetracycline nanoemulsion

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] An oil-in-water type compound aureomycin nanoemulsion, which consists of 6 parts of Magnolia bark water extract, 32 parts of surfactant (EL40), 4 parts of cosurfactant (ethanol), and 7 parts of aureomycin , oil (fatty acid glycerides) 11 parts, distilled water 40 parts.

[0033] Its preparation method is as follows:

[0034] 1) Weigh Magnolia officinalis water extract, surfactant, co-surfactant, chlortetracycline, oil and distilled water according to the above;

[0035] 2) Stir the surfactant, co-surfactant, chlortetracycline and oil evenly at room temperature to obtain an oil phase solution;

[0036] 3) Dissolving the Magnolia officinalis water extract in distilled water to obtain a distilled water phase solution;

[0037] 4) Add the distilled water phase solution into the oil phase solution and stir evenly to obtain the nanoemulsion.

Embodiment 2

[0039] An oil-in-water type compound aureomycin nanoemulsion, which consists of 5 parts of Magnolia bark water extract, 35 parts of surfactant (EL40), 5 parts of co-surfactant (1,2-propylene glycol), gold 5.5 parts of mycin, 14 parts of oil (ethyl butyrate), 35.5 parts of distilled water.

[0040] Its preparation method is with embodiment 1.

Embodiment 3

[0042] A kind of oil-in-water compound aureomycin nanoemulsion, its weight composition is: 4.5 parts of Magnolia bark water extract, 40 parts of surfactant (RH40), 5 parts of co-surfactant (glycerol), chlortetracycline 5.5 parts, 9 parts of oil (ethyl acetate), 36 parts of distilled water.

[0043] Its preparation method is with embodiment 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
The average particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention discloses oil-in-water compound chlortetracycline nanoemulsion, and belongs to the technical field of medicines. The oil-in-water compound chlortetracycline nanoemulsion comprises the following components in parts by weight: 1-18 parts of aqueous magnolia officinalis extract, 25-45 parts of a surfactant, 0-20 parts of a co-surfactant, 1-20 parts of chlortetracycline, 1-20 parts of oil and 20-70 parts of water. The oil-in-water compound chlortetracycline nanoemulsion has relatively narrow emulsion particle size distribution, is transparent, has high stability, relatively low surface tension and good mobility, and is convenient to take; a nanoemulsion preparation improves solubility and permeability of the chlortetracycline, so that the bioavailability of a medicine is improved; after the aqueous magnolia officinalis extract and the chlortetracycline are compounded, antibacterial abilities of the aqueous magnolia officinalis extract and the chlortetracycline are mutually promoted and enhanced, so that the antibacterial effect of the oil-in-water compound chlortetracycline nanoemulsion is more stable.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to an oil-in-water nanoemulsion-a compound antibacterial nanoemulsion with magnolia bark water extract and aureomycin as active ingredients. Background technique [0002] Aureomycin, English / Latin names: Chlortetracycline, Chlortetracycline, Aureomycin. CAS number: 57-62-5. EINECS No.: 200-341-7. Molecular formula: C 22 h 23 ClN 2 o 8 . Molecular weight: 478.8796. [0003] Chlortetracycline is a tetracycline antibiotic. Many rickettsia, mycoplasma, chlamydia, atypical mycobacteria, and spirochetes are sensitive to this product. Enterococci are resistant to it. Due to the widespread use of tetracyclines over the years, common clinical pathogens are seriously resistant to aureomycin, and Gram-positive bacteria such as Staphylococcus and most Enterobacteriaceae are drug-resistant. There is cross-resistance between this product and different varieties of tetracycl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/575A61K9/107A61P31/04A61K31/65
CPCA61K36/575A61K9/0053A61K9/107A61K31/65A61K47/10A61K47/22A61K47/44A61K2300/00
Inventor 孙江宏阮心洁李敏
Owner HENAN SOAR VETERINARY PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com